Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.66 |
| ▸ | CA2 | P00918 | 3/20 | 0.66 |
| ▸ | CA12 | O43570 | 2/20 | 0.66 |
| ▸ | CA7 | P43166 | 2/20 | 0.66 |
| ▸ | CA9 | Q16790 | 2/20 | 0.66 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.66 |
| ▸ | ESR1 | P03372 | 1/20 | 0.66 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.66 |
| ▸ | LMNA | P02545 | 2/20 | 0.63 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.63 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.63 |
| ▸ | MAOA | P21397 | 1/20 | 0.63 |
| ▸ | NHERF1 | O14745 | 1/20 | 0.63 |
| ▸ | HPGD | P15428 | 6/20 | 0.56 |
| ▸ | HTT | P42858 | 3/20 | 0.56 |
| ▸ | NPC1 | O15118 | 1/20 | 0.54 |
| ▸ | RAB9A | P51151 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | RECQL | P46063 | 1/20 | 0.53 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL274513 | 0.98 | CA1 (0.68) | CA1CA2CA12CA7CA9 | |
| SCHEMBL2989285 | 0.96 | CA12 (0.66) | CA1CA2CA12CA7CA9 | |
| SCHEMBL6705884 | 0.92 | CA12 (0.61) | CA1CA2CA12CA7CA9 | |
| SCHEMBL2270040 | 0.92 | CA12 (0.61) | CA1CA2CA12CA7CA9 | |
| Boric Acid SCHEMBL28174370 | 0.92 | CA12 (0.61) | CA1CA2CA12CA7CA9 | |
| SCHEMBL9805589 | 0.91 | NHERF1 (0.62) | CA1CA2CA12CA7CA9 | |
| SCHEMBL9678906 | 0.88 | CA12 (0.56) | CA1CA2CA12CA7CA9 | |
| SCHEMBL9678915 | 0.88 | CA12 (0.56) | CA1CA2CA12CA7CA9 | |
| SCHEMBL8266243 | 0.88 | NHERF1 (0.68) | CA1CA2CA12CA7CA9 | |
| SCHEMBL87450 | 0.87 | CA1 (0.83) | CA1CA2CA12CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110084230-A1 | Process for Synthesizing Organoelemental Compounds | LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN (DE) | 2011-04-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110084230-A1 | Process for Synthesizing Organoelemental Compounds | CHRM1, CHRM2, MLX | CA1 22/4885CA2 396/4885CA12 50/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.